Your browser doesn't support javascript.
loading
Saliva on the oral mucosa and whole saliva in women diagnosed with burning mouth syndrome.
Acharya, Shikha; Hägglin, Catharina; Jontell, Mats; Wenneberg, Bengt; Ekström, Jörgen; Carlén, Anette.
Affiliation
  • Acharya S; Department of Oral Microbiology and Immunology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Hägglin C; Department of Behavioural and Community Dentistry, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Jontell M; Centre of Gerodontology, Public Dental Service, Västra Götaland, Sweden.
  • Wenneberg B; Department of Oral Medicine and Pathology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Ekström J; Department of Orofacial Pain, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Carlén A; Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Oral Dis ; 24(8): 1468-1476, 2018 Nov.
Article in En | MEDLINE | ID: mdl-29917294
ABSTRACT

OBJECTIVE:

The aim of the study was to examine mucosal saliva and unstimulated (UWS) and stimulated (SWS) whole saliva secretion rates and associated factors, in 56 female patients diagnosed with BMS and age-matched control women. MATERIAL AND

METHODS:

Mucosal saliva was assessed using the Periotron® method and blood flow using laser Doppler flowmetry. Diseases, drug usage and xerostomia were registered using questionnaires.

RESULTS:

The patients with BMS displayed less lingual and whole saliva, and more hyposalivation, xerostomia diseases/disorders and drug usage, compared to the controls. Only a low SWS and xerostomia differed after adjusting for drugs and systemic diseases. Regression analyses suggested an importance of saliva affecting drugs for saliva on the tongue and for SWS, and the total number of drugs used for UWS. Lingual saliva and UWS were also associated with systemic diseases in the patients. Xerostomia was significantly associated with drug use and whole saliva for all subjects but not in separate analyses of the groups.

CONCLUSION:

Less saliva in patients with BMS could be related to more systemic diseases and medication and not to the syndrome per se. Xerostomia in the patients was not related to any of these factors.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Saliva / Burning Mouth Syndrome Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Oral Dis Journal subject: ODONTOLOGIA Year: 2018 Document type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Saliva / Burning Mouth Syndrome Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Oral Dis Journal subject: ODONTOLOGIA Year: 2018 Document type: Article Affiliation country: Sweden